ONCT

Oncternal Therapeutics, Inc. Common Stock
ONCT

Overview Fund Trends Analyst Outlook Journalist POV
Delisted

ONCT was delisted on the 2nd of December, 2024.

Back to rankings

36 hedge funds and large institutions have $7.51M invested in Oncternal Therapeutics, Inc. Common Stock in 2016 Q1 according to their latest regulatory filings, with 3 funds opening new positions, 3 increasing their positions, 7 reducing their positions, and 6 closing their positions.

New
Increased
Maintained
Reduced
Closed

less funds holding

Funds holding: →

less capital invested

Capital invested by funds: $ → $

less first-time investments, than exits

New positions opened: | Existing positions closed:

less repeat investments, than reductions

Existing positions increased: | Existing positions reduced:

Holders
36
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
–
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
$1K
Puts
–
Net Calls
Net Calls Change

Top Buyers

1
+$174K
2
+$17K
3
+$11K
4
Group One Trading
Group One Trading
Illinois
+$3.5K
5
Vanguard Group
Vanguard Group
Pennsylvania
+$2.1K

Top Sellers

1
-$44K
2
-$23.7K
3
-$15K
4
Susquehanna International Group
Susquehanna International Group
Pennsylvania
-$14K
5
Morgan Stanley
Morgan Stanley
New York
-$11.3K
Name Holding Trade Value Shares
Change 		Change in
Stake
26
$5K
27
$5K
28
$4K
29
$3K
30
$3K
31
$3K
32
$3K
33
$3K
34
$1K
35
$1K
36
$175
37
–
38
–
39
–
40
–
41
–
42
–
1
2